NASDAQ:QDEL - Quidel Stock Price, News, & Analysis

Quidel trades on the NASDAQ under the ticker symbol "QDEL."

Quidel Co. (NASDAQ:QDEL) issued its quarterly earnings data on Tuesday, August, 7th. The company reported $0.36 earnings per share (EPS) for the quarter, topping analysts' consensus estimates of $0.24 by $0.12. The firm had revenue of $103.16 million for the quarter, compared to the consensus estimate of $102.15 million. Quidel had a net margin of 4.63% and a return on equity of 19.39%. View Quidel's Earnings History.

Quidel is scheduled to release their next quarterly earnings announcement on Wednesday, November, 7th 2018. View Earnings Estimates for Quidel.

8 brokers have issued 12 month price targets for Quidel's shares. Their forecasts range from $47.00 to $80.00. On average, they expect Quidel's share price to reach $68.1667 in the next twelve months. This suggests that the stock has a possible downside of 3.9%. View Analyst Price Targets for Quidel.

8 Wall Street analysts have issued "buy," "hold," and "sell" ratings for Quidel in the last year. There are currently 6 buy ratings and 2 strong buy ratings for the stock, resulting in a consensus recommendation of "Buy." View Analyst Ratings for Quidel.

Some companies that are related to Quidel include Neogen (NEOG), Immunomedics (IMMU), Myriad Genetics (MYGN), Intellia Therapeutics (NTLA), Meridian Bioscience (VIVO), Lantheus (LNTH), Quotient (QTNT), Oxford Immunotec Global (OXFD), Nymox Pharmaceutical (NYMX), Riot Blockchain (RIOT), Trinity Biotech (TRIB), Celldex Therapeutics (CLDX), Vermillion (VRML), ImmuCell (ICCC) and Akers Biosciences (AKER).

Headlines about QDEL stock have trended somewhat negative on Saturday, Accern reports. The research firm identifies negative and positive press coverage by reviewing more than 20 million blog and news sources in real time. Accern ranks coverage of companies on a scale of negative one to positive one, with scores closest to one being the most favorable. Quidel earned a news impact score of -0.03 on Accern's scale. They also gave news articles about the company an impact score of 47.98 out of 100, indicating that recent press coverage is somewhat unlikely to have an impact on the stock's share price in the immediate future. View Recent Headlines for Quidel.

Quidel's stock is owned by a number of of retail and institutional investors. Top institutional shareholders include BlackRock Inc. (5.84%), Fred Alger Management Inc. (3.09%), OppenheimerFunds Inc. (2.31%), Dimensional Fund Advisors LP (2.33%), Macquarie Group Ltd. (2.13%) and Gabelli Funds LLC (1.65%). Company insiders that own Quidel stock include Charles P Slacik, Douglas C Bryant, Edward Keith Russell, Jack W Schuler, John Tamerius, Michael Donald Jr Abney, Randall J Steward, Ratan S Borkar, Robert Joseph Bujarski, Thomas D Brown and Werner Kroll. View Institutional Ownership Trends for Quidel.

QDEL stock was sold by a variety of institutional investors in the last quarter, including Point72 Asset Management L.P., Millennium Management LLC, Macquarie Group Ltd., Aristotle Capital Boston LLC, Renaissance Technologies LLC, Dimensional Fund Advisors LP, Eagle Boston Investment Management Inc. and Eagle Asset Management Inc.. Company insiders that have sold Quidel company stock in the last year include Charles P Slacik, Douglas C Bryant, Edward Keith Russell, Jack W Schuler, Randall J Steward, Ratan S Borkar, Robert Joseph Bujarski, Thomas D Brown and Werner Kroll. View Insider Buying and Selling for Quidel.

QDEL stock was purchased by a variety of institutional investors in the last quarter, including BlackRock Inc., Rothschild Asset Management Inc., Fuller & Thaler Asset Management Inc., Pier Capital LLC, Fred Alger Management Inc., Sei Investments Co., Massachusetts Financial Services Co. MA and Putnam Investments LLC. View Insider Buying and Selling for Quidel.

Shares of QDEL can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Scottrade, Fidelity and Charles Schwab.

One share of QDEL stock can currently be purchased for approximately $70.92.

Quidel has a market capitalization of $2.72 billion and generates $277.74 million in revenue each year. The company earns $-8,160,000.00 in net income (profit) each year or ($0.07) on an earnings per share basis. Quidel employs 1,193 workers across the globe.

Quidel's mailing address is 12544 HIGH BLUFF DRIVE SUITE 200, SAN DIEGO CA, 92130. The company can be reached via phone at 858-552-1100 or via email at [email protected]